The Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals Ltd. (Orchid), has announced that its cephalosporin API manufacturing complex located in Alathur, Chennai has successfully cleared the recent US FDA inspection that it went through. The facility manufactures a range of oral and sterile cephalosporin APIs and caters to the developed markets like USA, Europe and Japan.
This successful inspection would help the continuing supply of the niche APIs manufactured by Orchid in this location to the developed markets.